technescan mag3 1mg kit pro radiofarmakum
curium netherlands b.v., petten array - 10626 betiatid - kit pro radiofarmakum - 1mg - technecium-(99mtc) mertiatid
technescan pyp 20mg kit pro radiofarmakum
curium netherlands b.v., petten array - 11542 dekahydrÁt difosforeČnanu sodnÉho; 3122 dihydrÁt chloridu cÍnatÉho - kit pro radiofarmakum - 20mg - technecium-(99mtc) sn2+ Činidla, pro znaČenÍ bunĚk
technescan sestamibi 1mg kit pro radiofarmakum
curium netherlands b.v., petten array - 10321 tetrafluoroboritan tetramibimĚĎnÝ - kit pro radiofarmakum - 1mg - technecium-(99mtc) sestamibi
tenoretic 100mg/25mg potahovaná tableta
atnahs pharma netherlands b.v., amsterdam array - 4442 atenolol; 335 chlortalidon - potahovaná tableta - 100mg/25mg - atenolol a thiazidy
tenormin 100mg potahovaná tableta
atnahs pharma netherlands b.v., amsterdam array - 4442 atenolol - potahovaná tableta - 100mg - atenolol
tenormin 50mg potahovaná tableta
atnahs pharma netherlands b.v., amsterdam array - 4442 atenolol - potahovaná tableta - 50mg - atenolol
testavan 20mg/g transdermální gel
the simple pharma company limited, dublin array - 1422 testosteron - transdermální gel - 20mg/g - testosteron
thallous (tl201) chloride injection 37mbq/ml injekční roztok
curium netherlands b.v., petten array - 9673 chlorid thallnÝ-(201tl) - injekční roztok - 37mbq/ml - chlorid thallnÝ-(201tl)
lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - cytostatika - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
arexvy
glaxosmithkline biologicals s.a. - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infekce dýchacích syncyciálních virů - vakcíny - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. použití této vakcíny musí být v souladu s oficiálními doporučeními.